SCHEMBL5335644

SCHEMBL5335644

CC(C)(C)[Si](C)(C)OCc1cc(-c2c(Cl)cccc2Cl)no1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
L3MBTL1 Q9Y468 7/20 0.40
TDP1 Q9NUW8 4/20 0.40
POLB P06746 3/20 0.40
RAB9A P51151 8/20 0.39
NPC1 O15118 7/20 0.39
SMN1; SMN2 Q16637 6/20 0.39
HPGD P15428 1/20 0.39
STAT3 P40763 1/20 0.39
STAT1 P42224 1/20 0.39
CASP3 P42574 1/20 0.36
SENP8 Q96LD8 1/20 0.36
SENP7 Q9BQF6 1/20 0.36
SENP6 Q9GZR1 1/20 0.36
NOTUM Q6P988 1/20 0.36
ALDH1A1 P00352 3/20 0.36
KDM4E B2RXH2 1/20 0.36
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5334510 0.91 CHRNB2 (0.38) MAPTMEN1KMT2AL3MBTL1TDP1
SCHEMBL5802338 0.81 L3MBTL1 (0.38) MAPTMEN1KMT2AL3MBTL1TDP1
SCHEMBL5327885 0.79 RAB9A (0.45) MAPTMEN1KMT2AL3MBTL1TDP1
SCHEMBL5331359 0.77 NPC1 (0.38) MAPTL3MBTL1TDP1POLBRAB9A
SCHEMBL14591951 0.76 MAPT (0.43) MAPTMEN1KMT2AL3MBTL1TDP1
SCHEMBL1313922 0.75 NOTUM (0.44) MAPTMEN1KMT2AL3MBTL1TDP1
SCHEMBL5304332 0.73 NOTUM (0.58) MAPTMEN1KMT2AL3MBTL1TDP1
SCHEMBL27788975 0.73 NOTUM (0.62) MAPTMEN1KMT2AL3MBTL1TDP1
SCHEMBL3759539 0.71 MEN1 (0.31) MEN1KMT2A
SCHEMBL30723709 0.70 RAB9A (0.37) MAPTMEN1KMT2AL3MBTL1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007034445-A2 NOVEL PIPERAZINE DERIVATIVES AS RENIN INHIBITORS FOR CARDIOVASCULAR EVENTS AND RENAL INSUFFICIENCY ACTELION PHARMACEUTICALS LTD (CH) 2007-03-29 WO disclosed